RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Theralase on Global TV99942Apophis wrote: All 6 TMO sites have more than likely been in the loop as to where Shawn was in FDA approval, further I would suggest all 6 sites are proactive rather then reactive. Saying that in my thoughts are all 6 would have on going lists of patients who would be eligible to enter this trial with quick enrollment should this virus situation ease off. As far as Canada I believe would be in the same situation i. e.
ready to rock & roll TriumphSpitSix wrote
No no, I'm with you. Theralase is putting all the pieces together and things will be moving faster now with 4 US sites and more on the way. Pump all you want! Impalaman wrote: You could be RIGHT Truimph---HA-HA---I do have a slight hearing problem in my one ear 20%---but you can't blame me for pumping TLT.
Well said Apohpis...& US PIs will likely have 5-10X the patient base compared to the Canadian sites. Moreover, we should draw significant interest in the US simply based on the fact that PDT is more established & may be perceived as a more acceptable option. I also like the fact that there is no competitor trial "anywhere" that offers both a unique & promising type of treatment. In terms of other competitor trials, Keytruda is over & done with (boasting only marginal results ) & our next closest competitor (Anktiva aka N-803...used in combo with BCG) is further along in their Ph 2/3 trial. Interestingly, Roswell Park is a designated trial site for this drug.
As for Covid, fortunately, new case numbers are generally decreasing throughout North America. Also, patients in the US will not be treated in a higher-risk setting like a busy hospital/medical center, but rather at well-versed & well-protected ambulatory surgery centers. This pandemic is showing signs of weakening & I expect enrollment numbers are finally going to take off in the first half of this year...GLTA.